DHQ Hospital
Mānsehra, Khyber PkahtoonKhwa, 21300, Pakistan
Location status: Recruiting
Location contact
Ayesha Sabir, MSPT*
CONTACT
Ayesha Sabir, MSPT*
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07103512
To determine the additional effects of scalene hold relax technique with conventional exercises on pulmonary function in asthma patients
Interested in participating?
Request Info22 year–44 year
All sexes
Interventional
Not applicable
Mānsehra, Khyber PkahtoonKhwa, 21300, Pakistan
Location status: Recruiting
Ayesha Sabir, MSPT*
CONTACT
Ayesha Sabir, MSPT*
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Scalene Hold Relax Technique Scalene Hold for 10 Second 10 Repetition. Hold your arms behind your back to keep them from rising then slowly tilt your head trying to touch your ear to your shoulder. Bend your neck only as far as it is comfortable, and hold for 5 to 10 seconds. Relax your neck and repeat 2-3 times on each side. The treatment will be provided for 1-4 weeks as per need
Diaphragmatic Breathing Exercise Inhale through nose about 4 Seconds, hold Breath for 2 Seconds, repeat 5 times, exercise repeated for 2-3 days per week followed up to 4 weeks.
+ Buteyko Breathing Exercise Exhale slowly and then hold that breath. Use index figure and thumb to plug nose hold that breath until there is an urge to breathe and then inhale Breathe normally at least 10 second repeat several. Frequency 2-3 days per week with Moderate Intensity follow-up to 4weeks
Time frame: 4 week
A simple questionnaire Objective to measure the adequacy of asthma control and change in asthma control which occur either spontaneously or as a result of treatment ACQ has multidimensional construct assessing symptoms (5 items -self-administering and rescue in bronchodilator use (1 item-self-administered and FEV1%(1 item completed by clinic staff Test Retest reproducibility Reported with high intraclass correlation coefficient =0.90 Internal Consistency yes 7 point scale (0=no impairment =6 maximum impairment for symptoms and rescue use and 7categories for FEV1%) Minimally imp difference Change in score 0.5 7 items (score Range 0 (Totally controlled and 6 Severely Uncontrolled)
Time frame: 4 week
A patient self-administered tool for identifying those with poorly controlled asthma assess the frequency of shortness of breath and general asthma The Score Range from 5 (poor control of asthma) to 25 complete control of asthma) with higher scores reflecting greater asthma control. 5 items with 4-week recall on symptoms and daily functioning 5-point scale for symptom and activities 1=not controlled at all 5= completely controlled
Time frame: 4 week
The Lara Asthma Symptom Scale (LASS) is a validated tool designed to assess asthma symptoms in adults. It comprises eight questions that evaluate the frequency of various asthma-related symptoms over the past four weeks. Each question is scored on a 5-point Likert scale, where higher scores indicate more frequent symptoms. To interpret the LASS, sum the scores from all eight questions to obtain a total score ranging from 0 to 32. Higher total scores indicate more frequent and severe asthma symptoms, suggesting poorer asthma control.
Time frame: 4 week
Forced Expiratory Volume in 1 second, is a measurement of how much air a person can forcefully exhale from their lungs in one second.
Time frame: 4 week
Forced Vital Capacity, is a measurement of lung function assessed during spirometry. t represents the maximum amount of air that can be forcefully exhaled after a full inhalation.
Time frame: 4 week
Peak Expiratory Flow) spirometer, often a simple peak flow meter, is a device used to measure the speed of air exhaled from the lungs.
Contact information is provided by the study sponsor or research team.
Riphah International University
Other
Additional Effects of Scalene Hold Relax Technique With Conventional Physical Therapy On Pulmonary Function in Asthma Patient
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00341237
Asthma, Bronchial Diseases
Chapel Hill, North Carolina, United States
View Trial DetailsNCT07219173
Asthma, Bronchial Diseases
Tempe, Arizona, United States
View Trial DetailsNCT07228052
Asthma, Bronchial Diseases
The Bronx, New York, United States
View Trial DetailsNCT07556159
Asthma, Bronchial Diseases
Chandler, Arizona, United States
View Trial Details